Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 901–1,000 of 1,000
Induced pluripotent stem cells and cell therapy
İskender, B., & Canatan, H. (2013) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2013.04.0346
Yap, J. J. L., & Liew, R. (2014) · Journal of Arrhythmia · doi:10.1016/j.joa.2014.01.001
Recovery of myocardial tissue from extracted leads
Milan, D. J., & Rav-Acha, M. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.11.002
Modeling of Human Genetic Diseases Via Cellular, Reprogramming
Kang, M., Suh, J.-H., & Han, Y. (2012) · Journal of genetic medicine · doi:10.5734/jgm.2012.9.2.67
Mechanistic Basis for Atrial and Ventricular Arrhythmias Caused by KCNQ1 Mutations
Bartos, D. C. (2013) · UKnowledge (University of Kentucky)
Disease Modeling and Drug Discovery Using Human Pluripotent Stem Cells
Honoré, C., & Hansson, M. D. (2013) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4614-8066-2_15
Stem cells in rhythmology — Short communication
Földes, G. (2011) · Interventional Medicine and Applied Science · doi:10.1556/imas.3.2011.3.6
Cardiomyocytes from Human Embryonic Stem Cells
Xu, X. Q., Nandihalli, M., Tan, K. T., & Sun, W. Y. (2013) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201200007
Recent Advances in Cardiac Myocyte Biology and Function
Hong, K. U., & Moore, J. B. (2013) · Circulation Research · doi:10.1161/circresaha.113.302990
Dynamics in Biological Soft Materials
Hou, J. H. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Park, D. S., & Fishman, G. I. (2012) · Circulation · doi:10.1161/circulationaha.112.114165
Human Pluripotent Stem Cells in Cardiovascular Research and Regenerative Medicine
Poon, E. N.-Y., Kong, C., & Ronald, A. (2011) · InTech eBooks · doi:10.5772/23843
Hook, L. (2012)
Lemonnier, T. (2012) · theses.fr (ABES) · doi:10.70675/3c93f519z80e0z4221z9cf2zfce7eafbcb17
Kawaguchi, N., Hayama, E., Furutani, Y., Shimada, M., Okita, K., Nagashima, Y., Takeuchi, D., Matsuoka, R., & Nakanishi, T. (2015) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.31.313
iPS Cells and Cardiomyopathies
Nakahama, H., & Pasquale, E. D. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-18314-5_6
Induced Pluripotent Stem Cells in Familial Dilated Cardiomyopathy
Ng, K., Ho, J. C.-Y., Lee, Y.-K., Siu, C., & Tse, H. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-18314-5_2
Establishment and optimization of induced pluripotent stem cell technologies
Amir, M. (2013) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/55295
Rizzo, S. (2013) · Padua@research (University of Padova)
dos Santos, D. G. B. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-12082015-155410 · Cited by 2
Cardiomyocyte differentiation with cyclic mechanical strain
Zhao, E. J. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0166313
Application of iPS Cell Technology for Cardiac Disease Modeling and Repair
Sivarapatna, A. (2012) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000e105
Pluripotente stamceller mot lang QT-syndrom
Helland, Å. (2011) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.11.0272
Diogo Gonçalves Biagi dos Santos
Paulo, S. (2015)
Schulze‐Bahr, E., & Dittmann, S. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1883-2_62
Cardiac Arrhythmia Modelling Using iPS Cells
Yuasa, S. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_4
Stocum, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384860-4.00015-0
Ion Channel Expression and Function of iPSC-derived Cardiomyocytes
Furukawa, T. (2013) · CRC Press eBooks · doi:10.1201/b14990-10
Induced Cardiomyocytes: Direct Reprogramming for Cardiac Regeneration
Ieda, M. (2013) · CRC Press eBooks · doi:10.1201/b14990-16
Pluripotent Stem Cells in Toxicity Testing: An Omics Approach
Jagtap, S., Meganathan, K., & Wagh, V. (2016) · InTech eBooks · doi:10.5772/63929
Patient-Derived Induced Pluripotent Stem Cells to Target Kidney Disease
Barnes, F. J., & Ricardo, S. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00036-9
Modeling Arrhythmogenic Heart Disease with Patient-Specific Induced Pluripotent Stem Cells
Sinnecker, D., Goedel, A., Dirschinger, R. J., Moretti, A., & Laugwitz, K. (2013) · CRC Press eBooks · doi:10.1201/b14990-17
Stem Cell Technology and Cell Based Therapies
Davies, N., & Newsome, P. N. (2012) · Science Publishers eBooks · doi:10.1201/b11937-10
Crotti, L., Kotta, M., & Castelletti, S. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_7
Kang, H. Y., & Jeung, E. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-33270-3_2
Ahuja, V., Sharma, S., & Kamboj, R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782626787-00124
Human Stem Cell‐Derived Cardiomyocyte In Vitro Models for Cardiotoxicity Screening
Walker, T. M., Harris, K. L., Maifoshie, E., & Chaudhary, K. W. (2016) · Wiley eBooks · doi:10.1002/9781119135449.ch6
Qi, J. R. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5902 · Cited by 1
Differentiation of hiPSC-Derived Cardiomyocytes
Zanella, F., & Sheikh, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-30582-0_13
Congenital Heart Diseases and Disease-specific iPS Cells
Kobayashi, J., Sano, S., & Oh, H. (2015) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.31.138
Li, W. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6220
CÈL·LULES MARE EMBRIONÀRIES: QUÈ EN SABEM DESPRÉS DE TRENTA ANYS D'INVESTIGACIÓ?
Pulido, N. M., Arán, B., & Belmonte, J. C. I. (2012) · Estudis Romànics (Institut d'Estudis Catalans)
Rett Syndrome Induced Pluripotent Stem Cell-derived Neurons Exhibit Electrophysiological Aberrations
Farra, N. (2012) · TSpace (University of Toronto)
OBSOLETE: Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Advancing Cardiovascular Medicine
Hong, C. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.10919-5
Combining hiPSC and CRISPR/Cas9 technologies for studying cardiac disease and development
Dreizehnter, L. (2017) · mediaTUM (Technical University of Munich)
Cell Reprogramming for Cardiac Regeneration and Rare Disease Modeling
Carvajal‐Vergara, X., Rodríguez-Madoz, J. R., Pelacho, B., & Prósper, F. (2017) · Molecular and translational medicine · doi:10.1007/978-3-319-57153-9_9
Human iPSC-Derived Cardiac Myocytes: Toward an In Vitro Model of Cardiac Physiology
Wheelwright, M. (2017) · University of Minnesota Digital Conservancy (University of Minnesota)
Cheung, A. Y. L. (2013) · TSpace (University of Toronto)
Commercially Available Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Boldt, L., Parwani, A. S., & Heinzel, F. R. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001913
Generation and Application of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Schuldt, A. J. T., Romero‐Tejeda, M., & Burridge, P. W. (2017) · Cardiac and vascular biology · doi:10.1007/978-3-319-56106-6_4
Using an activator of hERG (RPR-260245) in a model of acquired and inherited Long QT syndrome type 2
Sergeev, V. (2017) · Summit (Simon Fraser University)
Modeling Atrial Fibrillation using Human Embryonic Stem Cells
Laksman, Z. (2015) · TSpace (University of Toronto)
Kurokawa, Y. K. (2017) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7db818f
Yip, J. K., & McCain, M. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00008-6 · Cited by 1
Modeling Atrial Fibrillation with Human iPSCs
Hong, L. (2018) · Open Access Journal of Cardiology · doi:10.23880/oajc-16000112
Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Towards Personalized Therapeutic Strategies?
Sinnecker, D., & Moretti, A. (2018) · Cardiac and vascular biology · doi:10.1007/978-3-319-77812-9_16
Kinin B2-Receptor in human iPSC differentiation into cardiomyocytes
Góes, M. E. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2018.tde-24092018-144907
Horváth, A. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10059
A Bioengineering Approach Towards Retina Regeneration
Mitrousis, N. (2018) · TSpace (University of Toronto)
Brugada, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00092-4
Stem cell therapy: An emerging treatment approach for atrial fibrillation
Hong, L. (2018) · Annals of Cardiology and Vascular Medicine · doi:10.33582/2639-4383/1001
Modeling Cardiomyopathies with iPSCs
Hulot, J. (2019) · Current human cell research and applications · doi:10.1007/978-981-13-3672-0_5
Mutations and Modifier Genes: Everything that Governs Congenital Long Qt Syndrome
Amritphale, N. (2018) · Journal of Cardiology & Cardiovascular Therapy · doi:10.19080/jocct.2018.12.555843
Ricardo, C. P. (2017) · Spiral (Imperial College London) · doi:10.25560/61778
Cardiac Diseases with Molecular and Clinical Aspect : JPH2-RyR2-SCN5A gene mutations
Vanninen, S. U. M. (2019) · Tampere University Institutional Repository (Tampere University)
Maia-Joca, R. P. M. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Cellular Reprogramming and Fate Conversion
Ieda, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-940-2_12
Kozek, K. A., Glazer, A. M., Ng, C.-A., Blackwell, D., Egly, C. L., Vanags, L. R., Blair, M., Mitchell, D., Matreyek, K. A., Fowler, D. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.17.952606
Study of calcium dynamics in hiPSC-derived cardiomyocytes
Moureen, F. (2019) · Työväentutkimus Vuosikirja · Cited by 1
Inheritable Potassium Channel Disease
Al‐Ahmad, A., & Wilde, A. A. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00051-0
Potta, S. P., Šarić, T., Heke, M., & Hescheler, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7696-2_23
Development of a Novel Platform for in vitro Electrophysiological Recording
Melle, G. (2020) · CINECA IRIS Institutial Research Information System (University of Genoa) · doi:10.15167/melle-giovanni_phd2020-03-11
Induced pluripotent stem cells for treatment of heart failure
Miyagawa, S., & Sawa, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00004-8
Induced pluripotent stem cell-derived cardiomyocytes
Regev, D., Baskin, P., Dolgopyat, I., Davidor, M., Kermani, F., Ullrich, N. D., & Binah, O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822230-0.00010-7 · Cited by 1
Induced Pluripotent Stem Cells
van Mil, A., Neef, K., Balk, G. M., Buikema, J. W., Sluijter, J. P. G., & Doevendans, P. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45457-9_26
Rat-Induced Pluripotent Stem Cells-Derived Cardiac Myocytes in a Cell Culture Dish
Dessouki, F. B. A., Singal, P. K., & Singla, D. K. (2021) · Methods in molecular biology · doi:10.1007/7651_2021_406
Sequelae of Genetic Defects in Cardiomyocytes
Kartha, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85536-9_10
Signaling pathways regulate cardiovascular lineage commitment of hPSCs
Han, P., & Cho, H. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00013-0
Role of ion channels in human induced pluripotent stem cells–derived cardiomyocytes
Treat, J. A., Jankova, M., Calløe, K., & Cordeiro, J. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00001-4
Christidi, E. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0402336
Yoshinaga, D., Makiyama, T., & Baba, S. (2021) · Japanese Journal of Electrocardiology · doi:10.5105/jse.41.124
The Regenerative Medicine for Heart Failure: From Transplant Therapy to In Vitro Study
Miyagawa, S. (2021) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.37.73
Induced pluripotent stem cells for modeling of cardiac arrhythmias
Sayed, Z. R. A., Corli, M., Masurkar, N. D., & Hulot, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00002-3
Differentiation and Use of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Földes, G., & Mioulane, M. (2012) · Springer eBooks · doi:10.1007/978-94-007-5645-8_7
Induced pluripotent stem cells for modeling cardiac sodium channelopathies
Makiyama, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823882-0.00002-3
Induced pluripotent stem cells for cystic fibrosis
Laselva, O., & Conese, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00014-1
Using human induced pluripotent stem cells to advance personalized/precision medicine
Leibel, S. L., McVicar, R. N., Bush, A., & Snyder, E. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00005-0
The Year in Clinical Cardiac Electrophysiology
Marcus, G. M., Scheinman, M. M., & Keung, E. C. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.058
Lin, L. Y., Barszczewski, T., Burgon, P. G., & Tibbits, G. F. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_44-1
Basic Physiology of Ion Channel Function
Baró, I., Escande, D., & Demolombe, S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4881-4_2
Eiges, R., Avitzour, M., & Reubinoff, B. E. (2012) · Informa Healthcare eBooks · doi:10.3109/9781841849713.030
Long, P., Shi, Y., Sun, F., Wei, Y., Wu, B., Li, Q., Jie, Q., & Ma, Y.-L. (2022) · Journal of clinical laboratory analysis (Print) · doi:10.1002/jcla.24464
慎介, 湯. (2015) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.23.2_268
hERG - Deficient Human Embryonic Stem Cell - Derived Cardiomyocytes for Modelling QT ProlongationPreprint
Chang, Y., Li, Y., Bai, R., Wu, F., Ma, S., Saleem, A., Zhang, S., Jiang, Y., Dong, T., Guo, T., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-225955/v1
Fiset, C. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732647626.793545494
Wei, H., Zhang, G., Qiu, S., Lu, J., Sheng, J., Manasi, G., Wong, P., Gan, S. U., & SHIM, W. S. N. (2013) · PLoS ONE · doi:10.1371/annotation/79d26ad0-169f-4440-8bee-4f483550112b
疾患 iPS 細胞を用いた遺伝性不整脈モデルの構築と病態解明
慎介, 湯. (2017) · Journal of JCS Cardiologists · doi:10.1253/jjcsc.25.1_61
Stem Cells - (Vol. 16, No. 3, Full Issue)
(2012) · Asia-Pacific Biotech News · doi:10.1142/s0219030312001024
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.